EUVIMEDEUVIMED entdecken
Open Access

Covariate‐Adjusted Group Sequential Comparisons of Survival Probabilities

Peter Zhang iD, Brent Logan, Michael J Martens

Statistics in Medicine · 2025

DOI: 10.1002/sim.70339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Peter Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Probability, Survival Analysis. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Office of Naval Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In confirmatory clinical trials, survival outcomes are frequently studied and interim analyses for efficacy and/or futility are often desirable. Methods including the log rank test and Cox regression model are commonly used for treatment comparisons, but are most efficient in a proportional hazards (PH) setting and are subject to a loss of power when PH are violated. Such violations may be expected a priori, particularly when the mechanisms of treatments differ such as immunotherapy versus chemotherapy for treating cancer. We propose group sequential tests for comparing survival probabilities with covariate adjustment that allow for interim analyses in the presence of non‐PH and offer easily interpreted, clinically meaningful summary measures of the treatment effect. The joint distribution of repeatedly computed test statistics possesses an independent increments structure asymptotically, facilitating marginal comparisons of survival probabilities in sequential studies by simplifying critical value specification to maintain Type I error control and sample size/power determination. Simulations demonstrate that the Type I error rate and power of the proposed tests meet targeted levels and are robust to the PH assumption and covariate influence. The proposed tests are illustrated using the Blood and Marrow Transplant Clinical Trials Network 1101 trial data ( https://www.clinicaltrials.gov #NCT01597778).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbabilitySurvival AnalysisHumansBone Marrow TransplantationComputer SimulationData Interpretation, StatisticalModels, StatisticalProportional Hazards ModelsClinical Trials, Phase III as TopicRandomized Controlled Trials as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

adjusted survival probabilityblood and marrow transplantationcovariate adjustmentgroup sequential designnonproportional hazards

Autor:innen und Institutionen

  • Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

ORCID-Profile: Peter Zhang

Förderung

  • NHLBI NIH HHS
  • Office of Naval Research
  • National Institute of Allergy and Infectious Diseases
  • NCI NIH HHS
  • Health Resources and Services Administration, Department of Health and Human Services
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Zhang, P., Logan, B., & Martens, M. J. (2025). Covariate‐Adjusted Group Sequential Comparisons of Survival Probabilities. Statistics in Medicine. https://doi.org/10.1002/sim.70339

Vancouver

Zhang P, Logan B, Martens MJ. Covariate‐Adjusted Group Sequential Comparisons of Survival Probabilities. Statistics in Medicine. 2025. doi:10.1002/sim.70339

BibTeX
@article{Zhang2025,
  author = {Zhang, Peter and Logan, Brent and Martens, Michael J},
  title = {Covariate‐Adjusted Group Sequential Comparisons of Survival Probabilities},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70339}
}
Kostenlos starten →